Technologies for the list were selected based on nominations. To be considered, the technologies had to meet four criteria — significant clinical impact and patient benefit over current technology, likelihood of commercial success, market availability starting 2015 and significant human interest in application/benefits. The list includes:
1. Mobile stroke units
2. Dengue fever vaccine
3. Quick, painless, low-cost blood testing
4. PCSK9 inhibitors for cholesterol reduction
5. Antibody-drug conjugates chemotherapy
6. Immune checkpoint inhibitors
7. Leadless cardiac pacemaker
8. New drugs for idiopathic pulmonary fibrosis
9. Single-dose intra-operative radiation therapy for breast cancer
10. New drug for heart failure Angiotensin-receptor neprilysin inhibitor
More articles on health IT:
12 recent vendor contracts, go-lives
Kaiser Permanete Hawaii patients can now send photos to physicians
Allscripts launches app for nurses
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
